Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03652545
Title Multi-antigen T Cell Infusion Against Neuro-oncologic Disease (REMIND)
Acronym REMIND
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Catherine Bollard
Indications
Therapies
Age Groups: child | senior | adult
Covered Countries USA


No variant requirements are available.